Plain-English translation of NCT03650595 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new treatment approach called focal laser ablation for men with low or intermediate-risk prostate cancer. Instead of removing the entire prostate or undergoing radiation therapy, this procedure uses a laser to destroy only the area of the prostate where cancer is found, guided by MRI imaging in real time. The goal is to treat the cancer while preserving more of the normal prostate function and avoiding the side effects of traditional treatments.
Many men with early-stage prostate cancer face a difficult choice: undergo major surgery or radiation therapy that can affect quality of life, or wait and watch for the cancer to progress. This trial exists to see whether this new treatment can safely eliminate or delay the need for these more invasive options, giving patients another choice.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will undergo the focal laser ablation procedure guided by MRI imaging. After treatment, you will return for follow-up visits at 6 months and 2 years, which include MRI scans, biopsies to check if cancer remains, and PSA blood tests at regular intervals. You will also complete short questionnaires about urinary and sexual function before the procedure and during follow-up visits to help researchers understand how the treatment affects your quality of life.
AI-generated summary from trial data · Jul 12, 2026 · Not medical advice
Canada